InnovAge Holding Corp (INNV)
Official siteHEALTHCARE • MEDICAL CARE FACILITIES • NASDAQ
Market Cap: $1.31B
Last updated: Nov 17, 2026 at 4:10 PM ET
InnovAge Holding Corp (INNV) Statistics
InnovAge Holding (INNV) has a market cap of $1.31B and an enterprise value of $1.24B. Its trailing P/E is 20.0x.
Total Valuation
Enterprise value is 4.95% below the market cap, as cash exceeds debt.
| Market Cap | $1.31B |
|---|---|
| Enterprise Value | $1.24B |
| Latest price (Nov 17, 2026) | $9.42 |
Key Dates
The next earnings report is expected on Feb 1, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Feb 1, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 3, 2026 |
| Fiscal Year End | June |
Valuation Ratios
Sales and book value multiples are 1.3x and 5.0x.
| P/E Ratio | 20.0x |
|---|---|
| Forward P/E | 20.5x |
| P/S Ratio | 1.3x |
| Forward P/S | 1.2x |
| P/B Ratio | 5.0x |
| P/TBV Ratio | 11.7x |
| P/FCF Ratio | 16.8x |
| P/OCF Ratio | 14.6x |
Enterprise Valuation
Counting debt and cash, the company is valued at 32.1x EBITDA and 16.0x free cash flow.
| EV / Earnings | 99.2x |
|---|---|
| EV / Sales | 1.2x |
| EV / EBITDA | 32.1x |
| EV / EBIT | 80.1x |
| EV / FCF | 16.0x |
Price Statistics
The stock is up 94.63% over 52 weeks and trades 0.42% below its 50-day average.
| Beta (1Y) | 0.93 |
|---|---|
| 52-Week Change | +94.63% |
| 1-Month Change | +6.08% |
| 3-Month Change | -13.89% |
| 6-Month Change | +30.65% |
| 5-Year Change | +38.82% |
| Total Return (1Y) | +94.63% |
| Total Return (3Y CAGR) | +18.09% |
| Total Return (5Y CAGR) | +2.08% |
| Return vs SPY (1Y) | +56.96% |
| Max Drawdown (1Y) | -33.21% |
| Max Drawdown (3Y) | -58.73% |
| Sharpe Ratio (1Y) | 0.82 |
| Correlation with SPY (1Y) | 0.20 |
| 50-Day Average | $9.46 |
| 200-Day Average | $9.27 |
| 52-Week Range | $4.70 to $12.64 |
| RSI (14 Days) | 51.7 |
| Average Volume (20 Days) | 517.10K |
The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 1.16x current liabilities, and total debt is 0.21x shareholder equity.
| Current Ratio | 1.16x |
|---|---|
| Quick Ratio | 1.16x |
| Debt / Equity | 0.21x |
| Debt / EBITDA | 1.44x |
| Debt / FCF | 0.71x |
Returns and Efficiency
Return on invested capital is 5.01% over the last 12 months, against a 5-year average of -5.44%.
| Return on Equity (ROE) | 4.91% |
|---|---|
| Return on Assets (ROA) | 2.23% |
| Return on Invested Capital (ROIC) | 5.01% |
| Return on Capital Employed (ROCE) | 4.19% |
| ROE (5Y Average) | -8.21% |
| ROA (5Y Average) | -4.04% |
| ROIC (5Y Average) | -5.44% |
| Asset Turnover | 1.90x |
| Receivables Turnover | 30.00x |
Scores
INNV has an Altman Z-Score of 4.57, in the safe zone above 2.99, and a Piotroski F-Score of 5 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 4.57 |
|---|---|
| Altman Z Zone | Safe |
| Piotroski F-Score | 5 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of $1.02B over the last 12 months is up 15.11% from the 12 months before.
| Revenue | $1.02B |
|---|---|
| Revenue Growth (YoY) | +15.11% |
| Gross Profit | $696.65M |
| Operating Income | $14.48M |
| Pretax Income | $12.39M |
| Net Income | $12.53M |
| EBITDA | $37.97M |
| EBIT | $15.52M |
| Reported EPS (TTM) | $0.47 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 45.36% of the $562.96M in total assets.
| Cash and Equivalents | $119.25M |
|---|---|
| Total Debt | $54.52M |
| Net Cash | $64.73M |
| Net Cash Per Share | $0.47 |
| Working Capital | $31.30M |
| Shareholder Equity | $255.34M |
| Book Value Per Share | $1.87 |
| Tangible Book Value | $110.24M |
| Tangible Book Per Share | $0.81 |
| Total Assets | $562.96M |
| Total Liabilities | $273.75M |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $13.22M of capital spending, operating cash flow left $76.31M of free cash flow.
| Operating Cash Flow | $89.53M |
|---|---|
| Capital Expenditures | $13.22M |
| Free Cash Flow | $76.31M |
| FCF Per Share | $0.56 |
| Depreciation and Amortization | $22.45M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is 1.42%, against a 5-year average of -2.81%.
| Gross Margin | 68.41% |
|---|---|
| Operating Margin | 1.42% |
| Pretax Margin | 1.22% |
| Net Margin | 1.23% |
| EBITDA Margin | 3.73% |
| EBIT Margin | 1.52% |
| FCF Margin | 7.49% |
| Gross Margin (5Y Average) | 70.07% |
| Operating Margin (5Y Average) | -2.81% |
| Net Margin (5Y Average) | -2.94% |
Growth
Revenue grew 12.88% a year over 3 years.
| Revenue Growth (3Y CAGR) | +12.88% |
|---|---|
| Revenue Growth (5Y CAGR) | +9.19% |
Dividends and Yields
INNV does not pay a dividend. Its free cash flow yield is 5.94%.
| Earnings Yield | 5.00% |
|---|---|
| FCF Yield | 5.94% |
Analyst Forecast
Consensus estimates put revenue growth at 8.25% and EPS growth at 11.80% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +8.25% |
|---|---|
| EPS Growth Forecast (2Y CAGR) | +11.80% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Fairly valued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About INNV
What is INNV's market cap?
InnovAge Holding has a market cap of $1.31B. Its enterprise value, which adds debt and subtracts cash, is $1.24B.
What is INNV's P/E ratio?
InnovAge Holding has a trailing P/E ratio of 20.0x and a forward P/E of 20.5x.
How many shares of INNV are outstanding?
InnovAge Holding has 136.41M shares outstanding. The count is up 0.61% from a year earlier.
Does INNV pay a dividend?
No. InnovAge Holding does not pay a dividend.
How much debt does INNV have?
InnovAge Holding has $54.52M of total debt and $119.25M of cash and equivalents, a net cash position of $64.73M.
INNV pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation